• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[在REACH注册研究中药物的使用:从指南到临床实践]

[Use of drugs in the REACH registry: from guidelines to clinical practice].

作者信息

Gómez Cerezo Jorge Francisco

机构信息

Hospital Infanta Sofía, San Sebastián de los Reyes, Madrid, España.

出版信息

Med Clin (Barc). 2009 Sep;132 Suppl 2:44-6. doi: 10.1016/S0025-7753(09)71754-3.

DOI:10.1016/S0025-7753(09)71754-3
PMID:19631840
Abstract

The REACH registry allows the degree of control of risk factors associated with atherothrombosis to be evaluated. Although 90% were taking at least one antihypertensive agent, hypertension was controlled in only 42.9% of the patients with vascular disease. This inadequate control may have multiple causes but the main factors are probably clinical inertia, lack of treatment adherence and the absence of combination therapies. Among patients with vascular disease, the percentage of those with good diabetes mellitus control was acceptable. The proportion of subjects with healthy cholesterol levels was suboptimal, even though 71.3% were receiving statins. The percentage of active smokers was 12% in the group of patients with vascular disease. More than 80% of the total population was taking at least one antiplatelet agent. Although the use of these agents is widespread in secondary prevention and that of lipid-lowering drugs is increasing, blood pressure and cholesterol goals are not being achieved in most patients with established vascular disease. In the REACH study, a substantial percentage of patients are not achieving adequate control of cardiovascular risk factors and are not receiving the treatments recommended in clinical practice guidelines.

摘要

REACH注册研究能够对与动脉粥样硬化血栓形成相关的危险因素的控制程度进行评估。尽管90%的患者至少服用了一种抗高血压药物,但在血管疾病患者中,仅有42.9%的患者高血压得到控制。这种控制不充分可能有多种原因,但主要因素可能是临床惰性、缺乏治疗依从性以及缺乏联合治疗。在血管疾病患者中,糖尿病控制良好的患者比例是可以接受的。尽管71.3%的患者正在接受他汀类药物治疗,但胆固醇水平正常的受试者比例仍不理想。在血管疾病患者组中,当前吸烟者的比例为12%。超过80%的总人口至少服用了一种抗血小板药物。尽管这些药物在二级预防中的使用很广泛,且降脂药物的使用也在增加,但大多数已确诊血管疾病的患者并未达到血压和胆固醇目标。在REACH研究中,相当比例的患者未能充分控制心血管危险因素,也未接受临床实践指南中推荐的治疗。

相似文献

1
[Use of drugs in the REACH registry: from guidelines to clinical practice].[在REACH注册研究中药物的使用:从指南到临床实践]
Med Clin (Barc). 2009 Sep;132 Suppl 2:44-6. doi: 10.1016/S0025-7753(09)71754-3.
2
[Implications of the REACH registry for neurologists].[REACH注册研究对神经科医生的启示]
Med Clin (Barc). 2009 Sep;132 Suppl 2:30-3. doi: 10.1016/S0025-7753(09)71750-6.
3
[Implications of the REACH registry for cardiologists].[REACH注册研究对心脏病专家的意义]
Med Clin (Barc). 2009 Sep;132 Suppl 2:15-20. doi: 10.1016/S0025-7753(09)71747-6.
4
[Implications of the REACH registry for vascular surgery].[REACH注册研究对血管外科的意义]
Med Clin (Barc). 2009 Sep;132 Suppl 2:25-9. doi: 10.1016/S0025-7753(09)71749-X.
5
[Implications of the REACH registry for endocrinologists].[REACH注册研究对内分泌科医生的启示]
Med Clin (Barc). 2009 Sep;132 Suppl 2:21-4. doi: 10.1016/S0025-7753(09)71748-8.
6
[The REACH registry: baseline and 1-year results].[REACH注册研究:基线和1年结果]
Med Clin (Barc). 2009 Sep;132 Suppl 2:5-9. doi: 10.1016/S0025-7753(09)71745-2.
7
[Implications of the REACH registry for internal medicine].[《化学品注册、评估、授权和限制制度》登记册对内科医学的影响]
Med Clin (Barc). 2009 Sep;132 Suppl 2:34-7. doi: 10.1016/S0025-7753(09)71751-8.
8
[One-year data from the REACH registry in Spain].[来自西班牙REACH注册研究的一年期数据]
Med Clin (Barc). 2009 Sep;132 Suppl 2:10-4. doi: 10.1016/S0025-7753(09)71746-4.
9
[Pharmacoeconomic analysis: results of the REACH registry].[药物经济学分析:REACH注册研究结果]
Med Clin (Barc). 2009 Sep;132 Suppl 2:41-3. doi: 10.1016/S0025-7753(09)71753-1.
10
[Risk factor control and treatment of atherothrombosis. Spain REACH Registry].[动脉粥样硬化血栓形成的危险因素控制与治疗。西班牙REACH注册研究]
Med Clin (Barc). 2007 Oct 6;129(12):446-50. doi: 10.1016/s0025-7753(07)72882-8.